NYSE:DVADavita Stock Price, Forecast & News

Davita's stock was trading at $74.87 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, DVA shares have increased by 5.1% and is now trading at $78.71. View which stocks have been most impacted by Coronavirus.

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Davita in the last year. There are currently 9 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Davita.

Davita is scheduled to release its next quarterly earnings announcement on Thursday, August 6th 2020. View our earnings forecast for Davita.

Davita Inc (NYSE:DVA) posted its earnings results on Tuesday, May, 5th. The company reported $1.83 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $1.47 by $0.36. The company earned $2.84 billion during the quarter, compared to the consensus estimate of $2.84 billion. Davita had a return on equity of 32.45% and a net margin of 7.85%. The company's revenue was up 3.6% on a year-over-year basis. During the same period last year, the firm posted $0.91 earnings per share. View Davita's earnings history.

Davita issued an update on its FY20 earnings guidance on Tuesday, May, 5th. The company provided earnings per share (EPS) guidance of $5.75-6.25 for the period, compared to the Thomson Reuters consensus estimate of $6.01. The company issued revenue guidance of $11.5-11.7 billion, compared to the consensus revenue estimate of $11.65 billion.

11 Wall Street analysts have issued 12 month price targets for Davita's shares. Their forecasts range from $57.00 to $90.00. On average, they anticipate Davita's share price to reach $68.86 in the next twelve months. This suggests that the stock has a possible downside of 12.5%. View analysts' price targets for Davita.

Press coverage about DVA stock has been trending somewhat positive this week, according to InfoTrie. InfoTrie identifies positive and negative press coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Davita earned a news impact score of 1.6 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View the latest news aboutDavita.

Davita saw a drop in short interest in the month of May. As of May 15th, there was short interest totaling 5,500,000 shares, a drop of 5.2% from the April 30th total of 5,800,000 shares. Based on an average daily trading volume, of 1,690,000 shares, the short-interest ratio is currently 3.3 days. Approximately 4.6% of the company's stock are sold short. View Davita's Current Options Chain.

Some companies that are related to Davita include Laboratory Corp. of America (LH), Quest Diagnostics (DGX), Chemed (CHE), Amedisys (AMED), LHC Group (LHCG), AMN Healthcare Services (AMN), MEDNAX (MD), R1 RCM (RCM), CorVel (CRVL), The Providence Service (PRSC), Tivity Health (TVTY), Cross Country Healthcare (CCRN) and Interpace Diagnostics Group (IDXG). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Davita investors own include CA (CA), BlackRock (BLK), Chipotle Mexican Grill (CMG), Endologix (ELGX), Aegean Marine Petroleum Network (ANW), Micron Technology (MU), United Rentals (URI), AutoZone (AZO), Walt Disney (DIS) and Gilead Sciences (GILD).

Davita trades on the New York Stock Exchange (NYSE) under the ticker symbol "DVA."

Davita's stock is owned by many different institutional and retail investors. Top institutional shareholders include BlackRock Inc. (5.90%), State Street Corp (3.71%), Bank of New York Mellon Corp (2.26%), Geode Capital Management LLC (1.36%), Invesco Ltd. (1.24%) and Robeco Institutional Asset Management B.V. (1.14%). Company insiders that own Davita stock include John M Nehra, Kent J Thiry, Pamela M Arway and Paul J Diaz. View institutional ownership trends for Davita.

DVA stock was sold by a variety of institutional investors in the last quarter, including Invesco Ltd., State Street Corp, Wedge Capital Management L L P NC, Paloma Partners Management Co, WINTON GROUP Ltd, KBC Group NV, BlackRock Inc., and California Public Employees Retirement System. Company insiders that have sold Davita company stock in the last year include John M Nehra, Kent J Thiry, Pamela M Arway, and Paul J Diaz. View insider buying and selling activity for Davita.

DVA stock was purchased by a variety of institutional investors in the last quarter, including Robeco Institutional Asset Management B.V., Bank of New York Mellon Corp, Janus Henderson Group PLC, PGGM Investments, Hexavest Inc., Pictet Asset Management Ltd., AJO LP, and Sumitomo Mitsui Trust Holdings Inc.. View insider buying and selling activity for Davita.

Shares of DVA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of DVA stock can currently be purchased for approximately $78.71.

Davita has a market capitalization of $9.59 billion and generates $11.39 billion in revenue each year. The company earns $810.98 million in net income (profit) each year or $5.40 on an earnings per share basis. Davita employs 65,000 workers across the globe.

The official website for Davita is www.davita.com.

Davita's mailing address is 2000 16TH STREET, DENVER CO, 80202. The company can be reached via phone at 720-631-2100 or via email at [email protected]